GO
Loading...

Enter multiple symbols separated by commas

Stocks Amgen Inc

More

  • So Much For The Summer Doldrums Friday, 1 Aug 2008 | 11:14 AM ET

    What a crazy week, right? Monday, Amgen had a huge upside revenue and earnings surprise. Tuesday, the Food and Drug Administration issued its new restrictions on the use of Amgen's anemia drugs in certain cancer patients. Later that same day, Elan and Wyeth released the big Alzheimer's drug test results.

  • Stocks Claw Back Prior Session's Losses Tuesday, 29 Jul 2008 | 5:19 PM ET

    It just goes to show you, a little attitude never hurts: Stocks clawed back all of the prior session's losses as oil hit its lowest point since May and consumer confidence improved.

  • Oil, Confidence Help Stocks Bounce Back Tuesday, 29 Jul 2008 | 3:57 PM ET

    It's all in the attitude today: Stocks rose after an improvement in consumer confidence.  Stocks were already pointing higher as oil prices receded but that little shot of confidence pushed the Dow up to a triple-digit gain.

  • Stocks Get a Boost From Rise in Confidence Tuesday, 29 Jul 2008 | 11:51 AM ET

    It's all in the attitude today: Stocks rose after an improvement in consumer confidence.  Stocks were already pointing higher as oil prices receded but that little shot of confidence pushed the Dow up to a triple-digit gain.

  • Election-Year Trades: Health Care Monday, 28 Jul 2008 | 5:53 PM ET

    Two strategists, Stephen Wood at Russell Investments and John Manley at Citi Smith Barney, shared their market rebound strategies with CNBC.

  • Dow Falls More Than 200 Points Monday, 28 Jul 2008 | 5:53 PM ET
    graphic_word_ofthe_street.jpg

    The Dow tumbled on Monday as more credit and housing market turmoil battered financial shares.

  • Amgen Earnings and Sales Rise, Top Forecasts Monday, 28 Jul 2008 | 5:11 PM ET
    Amgen

    Amgen reported a profit and sales that climbed higher and beat analysts' forecasts as sales of two key drugs topped expectations.

  • Major Indexes Fall Back Into Bear Territory Monday, 28 Jul 2008 | 5:03 PM ET

    Stocks declined Monday, led by financials after two more banks folded. Oil ticked higher after three straight weeks of decline, clipping consumer-discretionary stocks, including homebuilders, airlines and retailers.

  • Options Action: Merrill, Amgen, Medicals Monday, 28 Jul 2008 | 4:10 PM ET

    Merrill Lynch, Amgen, and some medical instrument outfits are getting a lot of options action this week, according to one observer.

  • Pipeline Of Profits! Monday, 28 Jul 2008 | 4:00 PM ET
    graphic_fast_money.jpg

    Pete Najarian reveals 3 biotechs he feels provide the most bang for the buck?

  • Financials Lead Decline After Bank Failures Monday, 28 Jul 2008 | 3:44 PM ET

    Stocks declined Monday, led by financials after two more banks folded. Oil ticked higher after three straight weeks of decline.

  • Stocks Trade Mixed as Oil Rises, Banks Wobble Monday, 28 Jul 2008 | 11:02 AM ET

    Stocks were mixed Monday as banks rallied and oil gained more than $1 a barrel.

  • Amgen Shares Leap on Osteoporosis Trial Results Monday, 28 Jul 2008 | 10:49 AM ET

    Shares of Amgen surged after the company reported positive trial results for its osteoporosis drug candidate denosumab—which one analyst terms "a future blockbuster."

  • Amgen's D-mab Delights Monday, 28 Jul 2008 | 10:38 AM ET
    AMGEN

    Amgen surprised the market late on a summer Friday by announcing positive test results from the big, crucial study of its experimental osteoporosis drug. The stock shot up after hours and continues to rally this morning.

  • Markets Best Sector Friday, 25 Jul 2008 | 6:52 PM ET

    In the last month healthcare has emerged as the best performing sector in the S&P. Are drug makers a cure for your portfolio in this economic downturn?

  • Friday's Top Videos: Gold, WaMu & More Friday, 25 Jul 2008 | 6:06 PM ET

    An analyst predicts that gold will head into a bull market, and Washington Mutual increases its liquidity position. The following are today's top videos:

  • Amgen Shares Leap on Osteoporosis Trial Results Friday, 25 Jul 2008 | 5:27 PM ET

    Amgen shares leaped in late trading Friday after the company said a pivotal trial of its experimental osteoporosis drug denosumab met its goal of significantly reducing the risk of bone fracture in post-menopausal women.

  • Best Trades Now: Tech, Utilities, Financials & More Thursday, 24 Jul 2008 | 3:30 PM ET

    To give investors an edge, CNBC asked the market experts for their best trades now.

  • Fannie, Freddie Rattle Market Friday, 11 Jul 2008 | 6:12 PM ET
    graphic_word_ofthe_street.jpg

    Fearing the two largest U.S. mortgage finance companies need a government bailout, investors pushed stocks lower Friday. What's the "Word On The Street?"

  • Pfizer, Merck And Lilly Partner Up To Get "Enlightened" Thursday, 10 Jul 2008 | 10:30 AM ET
    pfizer_hq.jpg

    Big pharma makes strange bedfellows. Pfizer, Merck and Eli Lilly this morning announced they've launched a joint venture of sorts called, "Enlight Biosciences". They're doing it with the help of the Boston-based VC firm PureTech Ventures.